Efficacy and safety of pembrolizumab in cervical cancer: Protocol for systematic review and meta-analysis of randomized clinical trials
The findings will be presented in narrative summary tables and a quantitative synthesis will be conducted using the 'meta' package of R software, version 4.3.1. This future systematic review may contribute with quality evidence for clinical decision-making on the use of pembrolizumab in women with cervical cancer.
Authors
- Kleyton Santos de Medeiros (ORCID: https://orcid.org/0000-0002-4105-7535)
- Andrea Juliana Gomes (ORCID: https://orcid.org/0000-0001-7388-663X)
- Ana Paula Ferreira Costa (ORCID: https://orcid.org/0000-0002-4511-4373)
- Amaxsell Thiago Barros de Souza (ORCID: https://orcid.org/0000-0002-7085-8788)
- Eduardo Pereira de Azevedo (ORCID: https://orcid.org/0000-0002-8630-6240)
- Juliana Dantas de Araújo Santos Camargo (ORCID: https://orcid.org/0000-0001-8692-5706)
- Ísis Kelly dos Santos (ORCID: https://orcid.org/0000-0001-7615-416X)
- Ricardo Ney Cobucci (ORCID: https://orcid.org/0000-0002-0184-2061)
- Ayane Cristine Alves Samento
- Dary Medeiros Dantas
Institutions
- Universidade Federal do Rio Grande do Norte (BR)
- Universidade Potiguar (BR)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-10-10
- DOI
- https://doi.org/10.1371/journal.pone.0312004
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior